End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.01 USD | -1.23% | -0.50% | +6.95% |
May. 08 | Oculis Holding AG Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 24 | H.C. Wainwright Adjusts Price Target on Oculis Holding to $28 From $29, Keeps Buy Rating | MT |
Business Summary
Number of employees: 36
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products and Substances
100.0
%
| - | - | 1 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Riad Sherif
CEO | Chief Executive Officer | 56 | 17-11-30 |
Sylvia Cheung
DFI | Director of Finance/CFO | 50 | 20-08-31 |
Ramin Tadayoni
CTO | Chief Tech/Sci/R&D Officer | 54 | Feb. 27 |
Rebecca Weil
PRN | Corporate Officer/Principal | - | 23-09-10 |
Bastian Dehmel
PRN | Corporate Officer/Principal | 54 | 21-12-31 |
Páll Jóhannesson
PRN | Corporate Officer/Principal | 44 | - |
Virginia R. Dean
HRO | Human Resources Officer | 58 | Feb. 27 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 71 | 18-03-31 | |
Director/Board Member | 69 | 23-03-02 | |
Director/Board Member | 58 | 23-03-02 | |
Lionel Carnot
BRD | Director/Board Member | 56 | 17-11-30 |
Director/Board Member | 59 | 23-03-02 | |
Pravin Dugel
BRD | Director/Board Member | 60 | 20-03-31 |
Riad Sherif
CEO | Chief Executive Officer | 56 | 17-11-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 41,649,705 | 38,633,278 ( 92.76 %) | 0 | 92.76 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.95% | 500M | |
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B |
- Stock Market
- Equities
- OCS Stock
- Company Oculis Holding AG